Why the price of heparin sodium reversed the rise

Since the 90s of the last century, mad cow disease in European and American countries has come and gone, and in order to ensure the quality and safety of heparin sodium products, European and American pharmaceutical companies have completely stopped purchasing heparin sodium extracted from European and American beef intestines and cow lungs, so it has objectively promoted the stability and upward trend of the price of intestinal heparin in pigs in China. At the end of March 2010, the global outbreak of influenza A (H1N1) in Mexico and the southwestern United States, the international market erected a barrier to Mexico's heparin exports, with the loss of mexican heparin market share, a large number of heparin purchase orders concentrated in China, for a time the demand for heparin increased greatly, and major heparin export companies have also increased the purchase price in order to win more heparin supply.

The 21st century is an era of aging populations. At present, all developed countries in the world have entered the aging meeting, and many developing countries are or will soon enter the aging meeting. The incidence of cardiovascular and cerebrovascular diseases is also increasing rapidly, so the demand for antithrombotic drugs in the global market will also increase.

In October last year, China implemented a nationwide retail guide price of essential drugs, and the heparin sodium injection for surgical anticoagulation was increased from the previous price of 4.5 yuan per 2 ml per bottle to 11.7 yuan. The pricing adjustment of drugs reflects the cost changes but also reflects the high quality and high price, especially after 08 years of "heparin sodium incident", the new United States Pharmacopoeia standard announced on October 1 last year not only improved the inspection methods of heparin sodium, but also comprehensively improved the acceptance standards for heparin sodium, Chinese enterprises have further strengthened production and quality management, so the final flow into the market is high potency, good quality heparin sodium, the price will continue to rise.

In the past few years, developed countries in Europe and the United States are the main export markets for China's heparin sodium API, but in recent years, some Eastern European countries such as Romania, Poland, Hungary, Bulgaria and Nordic countries such as Denmark and Finland have also become emerging markets for China's heparin sodium API export, and the export has accelerated rapidly. The price of heparin sodium has risen again and again due to the impact of market supply and demand factors.